NRT Smoking Cessation Aids in Poland

Publication Date	April 2009
Publisher	Euromonitor
Product Type	Report
Pages	32
ISBN Number	not applicable
Product Code	EUR00106

Buy this product or for assistance call +44 20 7060 7474

PDF £560.00$932 | €627

PRINT £560.00$932 | €627

FAX Order above formats by FAX

Summary

Euromonitor International's NRT Smoking Cessation Aids in Poland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.

Product coverage: NRT gum, NRT patches, NRT inhalators, other

Data coverage: market sizes (historic and forecasts), company shares, brand shares

Why buy this report?

Get a detailed picture of the smoking cessation aids industry
Pinpoint growth sectors and trends and identify factors driving change
Understand the competitive environment, the market's major players and leading brands
Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning

Content

NRT Smoking Cessation Aids in Poland
Euromonitor International
April 2009
Executive Summary
Increased Spending on OTC Drugs
New Innovative Products Fuel Demand
Multinationals Dominate Sales
Non-pharmacy Channel Sales Continue To Increase
Further Growth Expected
Key Trends and Developments
Health and Wellness Trend Increases in Popularity
Self-medication Increases in Popularity
Lifestyle and Environmental Changes Shape Consumer Behaviour
Innovations Fuel Growth
Increasing Child-specific Product Sales
Market Indicators
Market Data
$1OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
EU Legislation
Self-medication and Preventative Medicine
Generics
Re-classifications
Definitions
Aflofarm Farmacja Polska Sp Zoo
Strategic Direction
Key Facts
Company Background
Production
Competitive Positioning
Jelfa SA
Strategic Direction
Key Facts
Company Background
Production
Competitive Positioning
Polpharma SA
Strategic Direction
Key Facts
Company Background
Production
Competitive Positioning
Polski Lek SA
Strategic Direction
Key Facts
Company Background
Production
Competitive Positioning
Ppf Hasco-lek SA
Strategic Direction
Key Facts
Company Background
Production
Competitive Positioning
Headlines
Trends
Re-classifications
Competitive Landscape
Prospects
Sector Indicators
List of Summaries
- Summary 1 OTC healthcare Switches 2005-2007
- Summary 2 Research Sources
- Summary 3 Aflofarm Farmacja Polska Sp zoo: Key Facts
- Summary 4 Aflofarm Farmacja Polska Sp zoo: Operational Indicators
- Summary 5 Aflofarm Farmacja Polska Sp zoo: Production Statistics 2007
- Summary 6 Aflofarm Farmacja Polska Sp zoo: Competitive Position 2008
- Summary 7 Jelfa SA: Key Facts
- Summary 8 Jelfa SA: Operational Indicators
- Summary 9 Jelfa SA: Production Statistics 2007
- Summary 10 Jelfa SA: Competitive Position 2008
- Summary 11 Polpharma SA: Key Facts
- Summary 12 Polpharma SA: Operational Indicators
- Summary 13 Polpharma SA: Production Statistics 2007
- Summary 14 Polpharma SA: Competitive Position 2008
- Summary 15 Polski Lek SA: Key Facts
- Summary 16 Polski Lek SA: Operational Indicators
- Summary 17 Polski Lek SA: Production Statistics 2007
- Summary 18 Polski Lek SA: Competitive Position 2008
- Summary 19 PPF Hasco-Lek SA: Key Facts
- Summary 20 PPF Hasco-Lek SA: Operational Indicators
- Summary 21 PPF Hasco-Lek SA: Production Statistics 2007
- Summary 22 PPF Hasco-Lek SA: Competitive Position 2008
List of Tables
- Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
- Table 2 Life Expectancy at Birth 2003-2008
- Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
- Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
- Table 5 OTC Healthcare Company Shares by Value 2004-2008
- Table 6 OTC Healthcare Brand Shares by Value 2005-2008
- Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
- Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
- Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
- Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
- Table 11 Number of Smokers by Gender 2003-2008
- Table 12 Sales of Smoking Cessation Aids by Subsector: Value 2003-2008
- Table 13 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2003-2008
- Table 14 NRT Gum Flavours: % Value Breakdown 2006-2008
- Table 15 Smoking Cessation Aids Company Shares by Value 2004-2008
- Table 16 Smoking Cessation Aids Brand Shares by Value 2005-2008
- Table 17 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2008-2013
- Table 18 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2008-2013